TrialGut and liver2021

Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.

Gwang Ha Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.